Provided by Tiger Fintech (Singapore) Pte. Ltd.

Optinose Inc.

9.60
0.0000
Volume:- -
Turnover:7.77M
Market Cap:97.22M
PE:-3.59
High:9.60
Open:9.60
Low:9.60
Close:9.60
Loading ...

Paratek Pharmaceuticals Completes Acquisition of Optinose, Expands Specialty Therapies Portfolio

Reuters
·
21 May

Paratek Pharmaceuticals Completes Acquisition of OptiNose, Creating an Expanded Portfolio of Specialty Therapies

THOMSON REUTERS
·
21 May

Optinose Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
19 May

OptiNose Inc. Conducted Special Stockholder Meeting

Reuters
·
17 May

OptiNose Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

OptiNose Inc expected to post a loss of 74 cents a share - Earnings Preview

Reuters
·
09 May

OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
26 Mar

BRIEF-OptiNose Q4 Income From Operations USD 354 Thousand

Reuters
·
26 Mar

OptiNose: Q4 Earnings Snapshot

Associated Press Finance
·
26 Mar

OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek

Zacks
·
22 Mar

Optinose Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
21 Mar

Further Upside For OptiNose, Inc. (NASDAQ:OPTN) Shares Could Introduce Price Risks After 56% Bounce

Simply Wall St.
·
21 Mar

HC Wainwright Downgrades OptiNose to Neutral From Buy, Cuts Price Target to $9 From $18

MT Newswires Live
·
21 Mar

Why OptiNose Inc. (OPTN) Surged On Thursday?

Insider Monkey
·
21 Mar

U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose

Reuters
·
21 Mar

OptiNose Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $9 From $15

THOMSON REUTERS
·
21 Mar

Optinose Cut to Hold From Buy by Lake Street

Dow Jones
·
21 Mar

Sector Update: Health Care Stocks Mixed in Afternoon Trading

MT Newswires Live
·
21 Mar

Piper Sandler Downgrades OptiNose to Neutral From Overweight, $9 Price Target

MT Newswires Live
·
21 Mar

Optinose downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
21 Mar